Cue Biopharma (CUE) Liabilities and Shareholders Equity (2017 - 2026)
Cue Biopharma's Liabilities and Shareholders Equity came in at $30.71 million for Q2 2026, down 24.6% from $40.71 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Cue Biopharma's Liabilities and Shareholders Equity was $42.21 million, up 31.1% from FY2024.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -15.8% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $32.19 million in FY2024 (-47.7%), $61.53 million in FY2023 (-32.6%), $91.28 million in FY2022 (+9.5%) and $83.4 million in FY2021 (-16.2%).
- The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q1 2025.
- Year-over-year, Liabilities and Shareholders Equity increased in 1 of the last seven quarters, with an average decline of 24.0%.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2025 (growth of 31.1%), and the weakest in Q1 2025 (a decline of 58.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Cue Biopharma | 119.17 Mn | 28.44 Mn | - | 30.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.71 Mn |
| Dec 31, 2025 | 42.21 Mn |
| Sep 30, 2025 | 31.64 Mn |
| Jun 30, 2025 | 40.71 Mn |
| Mar 31, 2025 | 22.25 Mn |
| Dec 31, 2024 | 32.19 Mn |
| Sep 30, 2024 | 44.81 Mn |
| Jun 30, 2024 | 42.33 Mn |
| Mar 31, 2024 | 53.95 Mn |
| Dec 31, 2023 | 61.53 Mn |
| Sep 30, 2023 | 68.89 Mn |
| Jun 30, 2023 | 73.16 Mn |
| Mar 31, 2023 | 81.68 Mn |
| Dec 31, 2022 | 91.28 Mn |
| Sep 30, 2022 | 76.30 Mn |
| Jun 30, 2022 | 84.75 Mn |
| Mar 31, 2022 | 90.70 Mn |
| Dec 31, 2021 | 83.40 Mn |
| Sep 30, 2021 | 78.88 Mn |
| Jun 30, 2021 | 89.67 Mn |
API Access
Cue Biopharma Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();